Post-Lung Transplantation Bronchiectasis Clinical Trials
2 recruiting trials for Post-Lung Transplantation Bronchiectasis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Post-Lung Transplantation Bronchiectasis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
The only sponsor on record for these trials is Mayo Clinic (2 trials).
The most frequently studied intervention is POWERBreathe Plus® (device, 1 trial), followed by Cardiopulmonary rehabilitation post lung transplant, Lung ultrasound.
Track Post-Lung Transplantation Bronchiectasis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant
The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and...
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
This study is being done to study a safe and non-invasive way to diagnose lung rejection and infection.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Post-Lung Transplantation Bronchiectasis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Post-Lung Transplantation Bronchiectasis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Post-Lung Transplantation Bronchiectasis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.